These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8395447)

  • 21. [Who in The Netherlands is eligible for immunization with inactivated hepatitis A vaccine?].
    Leentvaar-Kuijpers A
    Ned Tijdschr Geneeskd; 1994 May; 138(19):941-2. PubMed ID: 8196784
    [No Abstract]   [Full Text] [Related]  

  • 22. Travel prophylaxis. Assumptions were confusing.
    Van Damme P; Van Doorslaer E; Tormans G; Beutels P
    BMJ; 1995 Feb; 310(6976):402. PubMed ID: 7866237
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
    Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
    [No Abstract]   [Full Text] [Related]  

  • 24. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 25. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.
    Armstrong ME; Giesa PA; Davide JP; Redner F; Waterbury JA; Rhoad AE; Keys RD; Provost PJ; Lewis JA
    J Hepatol; 1993; 18 Suppl 2():S20-6. PubMed ID: 8182268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How an outbreak of hepatitis A in Melbourne led to the development of a vaccine.
    Gust ID
    Vaccine; 1992; 10 Suppl 1():S9. PubMed ID: 1335669
    [No Abstract]   [Full Text] [Related]  

  • 28. The value of immunization against hepatitis A.
    Lemon SM; Shapiro CN
    Infect Agents Dis; 1994 Feb; 3(1):38-49. PubMed ID: 7952926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Travel prophylaxis. Journals should develop guidelines for economic evaluations.
    Backhouse ME
    BMJ; 1995 Feb; 310(6976):402. PubMed ID: 7866238
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis A vaccination: a sensible luxury?].
    Holzer RB
    Schweiz Rundsch Med Prax; 1993 Feb; 82(7):183-5. PubMed ID: 8382372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of hepatitis A vaccines.
    Gust ID
    Br Med Bull; 1990 Apr; 46(2):319-28. PubMed ID: 2165843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The specific safety of a cultured inactivated vaccine against hepatitis A].
    Kusov IuIu; Orlova TM; Panina LI; Kazachkov IuA; Nel'ga IV; El'bert LB; Krutianskaia GL; Poleshchuk VF; Sobol' AV; Titova IP
    Vopr Virusol; 1991; 36(2):156-9. PubMed ID: 1652870
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity of hepatitis A virus vaccine in primates.
    Chaudhary RK; Mo T
    J Infect Dis; 1990 Mar; 161(3):586-7. PubMed ID: 2155977
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatitis A inoculation].
    Jilg W
    Dtsch Med Wochenschr; 1994 Dec; 119(51-52):1800. PubMed ID: 7736937
    [No Abstract]   [Full Text] [Related]  

  • 35. Quarterly communicable disease review. July to September 1992. From the PHLS Communicable Disease Surveillance Centre.
    George RC; Heptonstall J; Morse D; Reeves WG; Teper S
    J Public Health Med; 1993 Mar; 15(1):103-11. PubMed ID: 8385968
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis A and B vaccines in children.
    Lieberman JM; Greenberg DP
    Adv Pediatr Infect Dis; 1996; 11():333-63. PubMed ID: 8718466
    [No Abstract]   [Full Text] [Related]  

  • 37. The success of hepatitis A vaccine.
    Sjogren MH
    Gastroenterology; 1993 Apr; 104(4):1214-6. PubMed ID: 8385043
    [No Abstract]   [Full Text] [Related]  

  • 38. [The future of viral hepatitis vaccines].
    Shdanov VM
    Z Gesamte Hyg; 1985 Mar; 31(3):134-7. PubMed ID: 2990115
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults.
    McMahon BJ; Williams J; Bulkow L; Snowball M; Wainwright R; Kennedy M; Krause D
    J Infect Dis; 1995 Mar; 171(3):676-9. PubMed ID: 7876615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatitis A virus infection.
    Moyer L; Warwick M; Mahoney FJ
    Am Fam Physician; 1996 Jul; 54(1):107-14. PubMed ID: 8677827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.